Comparison of four novel biomarkers alongside NT-proBNP for risk assessment of heart failure or death within 1 year from admission with acute dyspnoea

1 September 2025 (09:09 - 09:27)
Organised by: Logo
Congress Presentation Part of: Refining diagnosis in heart failure Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by